Ebola drug trial stops adding patients
A PHARMACEUTICAL company has stopped adding patients to a trial of a potential treatment for a strain of Ebola.
CANADIAN drugmaker Tekmira says it has stopped enrolling new patients in a trial of a treatment for a strain of Ebola.
THE company says the mid-stage study has "reached a predefined statistical endpoint" and it is no longer enrolling patients.